Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Chu, Van Trung Dr. (1) Daniel, Peter Prof. Dr. (2) Di Virgilio, Michela Prof. Dr. (1) Graf, Robin Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lewin, Gary Prof. Dr. (1) Lusatis, Simone (1) Mastrobuoni, Guido Dr. (1) Mathas, Stephan Dr. (9) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Siffrin, Volker (1) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (3) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zinzen, Robert Patrick Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (13) (-) Wollert-Wulf, Brigitte (3) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (13) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (4) (-) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 16 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199720062015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. Januar 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. Januar 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein